Cargando…

Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity

Tumor progression is facilitated immunologically by mechanisms that include low antigen expression, an absence of coimmunostimulatory signals, and the presence of regulatory T cells (Tregs), all of which act to suppress and restrict effector T cells in the tumor. It may be possible to overcome these...

Descripción completa

Detalles Bibliográficos
Autores principales: Villarreal, Daniel O., Chin, Diana, Smith, Melissa A., Luistro, Leopoldo L., Snyder, Linda A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503599/
https://www.ncbi.nlm.nih.gov/pubmed/28388572
http://dx.doi.org/10.18632/oncotarget.16605